SEC 13F Intelligence

Villanova Investment Management Co LLC / SUPN

Villanova Investment Management Co LLC’s Supernus Pharmaceuticals Position

Does Villanova Investment Management Co LLC own Supernus Pharmaceuticals (SUPN)? Yes — 34.9K shares worth $2M (+1.85% of its 13F portfolio) as of Q1 2026, down from 48.1K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
34.9K
% of Portfolio
+1.85%
Quarters Held
7
currently held

Position History SUPN

Reported value by quarter
Q3 ’24: $2MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $2MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $3MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202634.9K$2M+1.85%
Q4 202548.1K$2M+1.68%
Q3 202554.9K$3M+1.82%
Q2 202552.3K$2M+1.71%
Q1 202519.6K$2M+1.85%
Q4 202457.0K$2M+1.84%
Q3 202451.5K$2M+1.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Villanova Investment Management Co LLC’s full portfolio or all institutional holders of SUPN.